Acelyrin, Inc. Share Price: SLRN (Acelyrin, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Acelyrin, Inc. share price today?

Accepted Answer

Acelyrin, Inc. (SLRN) share price today is {{live_price}}.

Question 2

Can Indians buy Acelyrin, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Acelyrin, Inc. (SLRN) from India.

With INDmoney, you can buy Acelyrin, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Acelyrin, Inc. at zero transaction cost.

Question 3

How can I buy Acelyrin, Inc. shares from India?

Accepted Answer

It is very easy to buy Acelyrin, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Acelyrin, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Acelyrin, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Acelyrin, Inc. stocks?

Accepted Answer

To start investing in Acelyrin, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Acelyrin, Inc.

Accepted Answer

Today’s highest price of Acelyrin, Inc. (SLRN) is {{1_rba_end}}.

Today’s lowest price of Acelyrin, Inc. (SLRN) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Acelyrin, Inc.

Accepted Answer

Today's market capitalisation of Acelyrin, Inc. SLRN is 456.6M

Question 8

What is the 52 Week High and Low Range of Acelyrin, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Acelyrin, Inc. is down from its 52 Week High?

Accepted Answer

Acelyrin, Inc. (SLRN) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Acelyrin, Inc. is up from its 52 Week low?

Accepted Answer

Acelyrin, Inc. (SLRN) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Acelyrin, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Acelyrin, Inc.

Accepted Answer

Ms. Melanie  Gloria B.S.N. is the current Chief Executive Officer (CEO) of Acelyrin, Inc..

Period	Acelyrin, Inc.	Index (Russel 2000)
3 Months	-4.93%	0.0%
6 Months	-49.58%	0.0%
1 Year	-84.3%	0.0%
3 Years	-81.96%	-22.3%

Market Capitalization	456.6M
Book Value	$5.71
Earnings Per Share (EPS)	-1.94
Wall Street Target Price	10.5

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-35.63%
Return On Equity TTM	-43.79%

Revenue TTM	0.0
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
EBITDA	-423.6M
Diluted Eps TTM	-1.94
Quarterly Earnings Growth YOY	0.0

Acelyrin, Inc. (SLRN)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Vs REGN

Company Information

Discover More

FAQs

EPS Estimate Current Year	-2.95
EPS Estimate Next Year	-2.1
EPS Estimate Current Quarter	-0.75
EPS Estimate Next Quarter	-0.8

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Acelyrin, Inc.	-14.17%	-49.58%	-84.3%	-81.96%	-81.96%
Regeneron Pharmaceuticals, Inc.	5.97%	16.25%	37.11%	69.18%	305.56%
Novo Nordisk A/s	9.99%	-3.52%	34.24%	158.74%	417.73%
Alnylam Pharmaceuticals, Inc.	-5.15%	64.67%	22.72%	31.08%	198.44%
Vertex Pharmaceuticals Incorporated	0.45%	14.0%	36.06%	143.5%	167.72%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Acelyrin, Inc.	NA	NA	NA	-2.95	-0.44	-0.36	NA	5.71
Regeneron Pharmaceuticals, Inc.	29.93	29.93	1.54	45.05	0.17	0.08	NA	261.41
Novo Nordisk A/s	44.01	44.01	1.98	3.44	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.55	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.57	0.32	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Acelyrin, Inc.	Buy	$456.6M	-81.96%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$124.7B	305.56%	29.93	32.04%
Novo Nordisk A/s	Buy	$585.3B	417.73%	44.01	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$32.3B	198.44%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$120.9B	167.72%	32.84	-4.74%

Organization	Acelyrin, Inc.
Employees	93
CEO	Ms. Melanie Gloria B.S.N.
Industry	Miscellaneous